See the DrugPatentWatch profile for yervoy

Yervoy, also known as ipilimumab, is a medication used to treat melanoma, a type of skin cancer, and certain types of kidney and lung cancer. Like all medications, Yervoy can have side effects, some of which can be serious.

According to the drug's manufacturer, Bristol Myers Squibb, common side effects of Yervoy include fatigue, diarrhea, skin rash, and itching. More serious side effects can include liver problems, intestinal problems, hormonal problems, and skin problems. In rare cases, Yervoy can cause severe immune-related side effects that can be life-threatening.

While it is not possible to prevent all side effects of Yervoy, there are steps that can be taken to reduce the risk of serious side effects. According to Bristol Myers Squibb, it is important for patients to tell their healthcare provider about any symptoms they experience while taking Yervoy. This includes both common and serious side effects.

Healthcare providers may also take steps to monitor patients for signs of serious side effects. For example, they may order blood tests to check liver function or perform other tests to monitor the patient's overall health.

It is also important for patients to follow their healthcare provider's instructions carefully when taking Yervoy. This includes taking the medication as directed and avoiding missed doses. Patients should also tell their healthcare provider about any other medications they are taking, as well as any medical conditions they have, as these factors can affect the safety and effectiveness of Yervoy.

In addition, it is worth noting that the patent for Yervoy expired in the United States in 2020, which may lead to the availability of generic versions of the drug in the future. This could potentially increase access to the medication and reduce its cost, making it more accessible to patients who need it.

In summary, while it is not possible to prevent all side effects of Yervoy, there are steps that can be taken to reduce the risk of serious side effects. These include monitoring for symptoms, following healthcare provider instructions, and staying up-to-date on the availability of generic versions of the drug.

Sources:

1. Bristol Myers Squibb. (2021). Yervoy (ipilimumab) injection, for intravenous use. <https://packageinserts.bms.com/pi/pi_yervoy.pdf>
2. DrugPatentWatch. (2021). Yervoy (ipilimumab) patent. <https://www.drugpatentwatch.com/drugs/yervoy>